3D Medical : 3DM announces first sale under the eUnity distribution agreement

0b33d56f-888b-46fe-a4f3-f1774b2d7dc8.pdf

ASX Announcement 18 January 2016

3DM announces first sale under the eUnity distribution agreement

• Five-year sales contract for the eUnity medial image viewer
• $200,000 in revenue to be generated for customization of software
• Annual subscription fee for maximum number of studies plus incremental fee for excess volume of studies
• 3DM expects further sales success for the eUnity medical image viewer

3D Medical Limited (ASX: 3DM) (3DM or the Company) is pleased to announce that it has made its first sale (Agreement) under the distribution agreement for the eUnity™ medical image viewing and collaboration platform.

As previously announced on 30 November 2015, the Company has been appointed for an initial five-year term to distribute Client Outlook Inc.'s eUnity medical image software products globally and generate fees based on the number of radiology images examined through the software.

The first sale is a five-year Agreement and allows for approximately $200,000 in revenue to be paid to 3DM in the coming months for various software development work to configure the eUnity medical image viewer to suit the specific requirements of 3DM's initial enterprise customer.

In addition, 3DM will earn an annual subscription fee under the 5-year Agreement for a finite number of medical image studies that the customer can view via the eUnity medical image software.

Where the customer views medical image studies in excess of the agreed annual volume, an incremental "per study" fee will be charged to the customer each quarter.

As is common under an Agreement of this type, the specific terms regarding minimum number of studies, as well as the annual and incremental licence fees shall remain commercially confidential.

Dr Nigel Finch, Chairman of 3DM commented that "this first sale of the eUnity viewer demonstrates 3DM's ability to identify leading-edge applications and to commercially deploy these applications with leading healthcare professionals. We would expect further sales success in the near term distributing the eUnity medical image software in our target markets".

- ENDS

For more information, contact:

3D Medical Limited

Dr Nigel Finch, Chairman ([phone]) Email: [e-mail]

Web: www.3Dmedical.com.au

About 3D Medical Limited:

At 3D Medical our aim is to aid medical professionals in the facilitation of improved clinical care, improving medical procedures, diagnostics and ultimately improving patient outcomes. 3D Medical is a medical specific 3D printing and holographic projection and data integrations provider. Our services 3D Medical Printing; EchoPixel (holographic projection technology); GestSure (in surgery image control); Mach7 (enterprise imaging solution provides healthcare organisations with the ability to archive, consolidate, access, and share medical imaging data across departments, locations and regions); and MediDATA provide medical practices the opportunity to leverage their analytical capabilities to gain an improved understanding of the characteristics of the patients which drive their business. These new and innovative products leverage data already captured by conventional imaging modalities and apply it in more meaningful ways to deliver improved economic and patient outcomes. On 26 October 2015, 3D Medical announced that it had entered into a binding merger agreement with Mach7 Technologies. Subject to shareholder approval, and upon successful completion of the merger, 3D Medical will change its name to Mach7 Technologies.

About Mach7 Technologies:

Mach7 Technologies is a global provider of enterprise image management systems that allow healthcare enterprises to easily identify, connect, and share diagnostic image and patient care intelligence where and when needed. Mach7's award-winning platform delivers image management including rapid record identification, integration, synchronization and routing, advanced clinical viewing, and optimized vendor neutral archiving. Mach7 has locations in the U.S., Asia, Australia, and the Middle East.

For more information, visit www.mach7t.com